Amy Hamm: Ozempic is the end of fat activism
The drug's popularity shows that most people — even the body-positive ones — don't want to be obese
You can save this article by registering for free here. Or sign-in if you have an account.
Ever since Ozempic hit the market as a weight-loss drug, fat activists of the world appear to have been cycling (not literally, of course) between the five stages of grief.
Enjoy the latest local, national and international news.
Enjoy the latest local, national and international news.
Create an account or sign in to continue with your reading experience.
Create an account or sign in to continue with your reading experience.
There has been anger: one learned fat scholar suggested in 2023 that weight-loss drugs like Ozempic “relate to eugenicist social practices.” Some accused persons who lost weight of having undergone conversion therapy — because there seems to be no historical struggle or oppression that these activists aren’t willing to appropriate for their cause.
Other activists reached the “acceptance” stage very early on, even before half of Hollywood dropped a collective 10 dress sizes: a Guardian headline from two years ago claimed that “Ozempic has won, body positivity has lost, and I want no part of it.”
This newsletter tackles hot topics with boldness, verve and wit. (Subscriber-exclusive edition on Fridays)
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
A welcome email is on its way. If you don't see it, please check your junk folder.
The next issue of Platformed will soon be in your inbox.
We encountered an issue signing you up.........
